Trial Profile
Azithromycin in Post Diarrheal Haemolytic and Uremic Syndrome
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Oct 2021
Price :
$35
*
At a glance
- Drugs Azithromycin (Primary)
- Indications Haemolytic uraemic syndrome
- Focus Therapeutic Use
- Acronyms ZITHROSHU
- 01 Oct 2021 Status changed from recruiting to completed.
- 01 Mar 2018 Planned End Date changed from 1 Jul 2019 to 1 Oct 2021.
- 01 Mar 2018 Planned primary completion date changed from 1 Jul 2018 to 1 Oct 2020.